Tests in vivo in SCLC and in clinical trials in additional solid tumors, show that ONC201 works by increasing cellular stress and inducing TRAIL-mediated apoptosis in the p53 pathway in several tumor cell lines. The gene discussed is TP53; the disease is small cell lung carcinoma.